Glycolysis Pathway

From Pepperpedia, the free peptide encyclopedia
Glycolysis Pathway
Properties
CategoryMechanisms
Also known asglycolysis, Embden-Meyerhof-Parnas pathway
Last updated2026-04-14
Reading time4 min read
Tags
mechanismmetabolismglucose

Overview

Glycolysis is the fundamental catabolic pathway that converts glucose into pyruvate, generating a small net yield of ATP and NADH. Conserved across all domains of life, it occurs in the cytoplasm and operates under both aerobic and anaerobic conditions. Under aerobic conditions, pyruvate enters the mitochondrion for oxidation in the TCA cycle and oxidative phosphorylation; under anaerobic or highly proliferative conditions, pyruvate is reduced to lactate by lactate dehydrogenase, regenerating NAD+ for sustained glycolytic flux.

The ten enzymatic steps of glycolysis can be organized into two halves. The preparatory phase (steps 1-5) consumes two ATP to phosphorylate and split glucose into two triose phosphates. The payoff phase (steps 6-10) generates four ATP and two NADH as the triose phosphates are oxidized and rearranged into pyruvate. The net yield is 2 ATP and 2 NADH per glucose.

Beyond energy, glycolytic intermediates serve as biosynthetic precursors: glucose-6-phosphate feeds the pentose phosphate pathway; fructose-6-phosphate supports hexosamine synthesis; dihydroxyacetone phosphate enters triacylglycerol synthesis; and 3-phosphoglycerate is a precursor of serine. Glycolysis is thus a central metabolic hub, with regulation that integrates energy status, hormonal signaling (insulin, glucagon), and proliferative demand.

Mechanism / Process

  1. Glucose uptake. Glucose enters cells via glucose transporters (GLUT1-4 primarily) and is phosphorylated by hexokinase (or glucokinase in liver and beta cells) to glucose-6-phosphate, trapping it inside the cell.

  2. Isomerization. Phosphoglucose isomerase converts glucose-6-phosphate to fructose-6-phosphate.

  3. Second phosphorylation (commitment step). Phosphofructokinase-1 (PFK-1) phosphorylates fructose-6-phosphate to fructose-1,6-bisphosphate, using a second ATP. This is the major regulatory step of glycolysis.

  4. Cleavage. Aldolase splits fructose-1,6-bisphosphate into glyceraldehyde-3-phosphate (G3P) and dihydroxyacetone phosphate (DHAP). Triose phosphate isomerase interconverts the two, so both enter the payoff phase as G3P.

  5. Oxidation and phosphorylation. Glyceraldehyde-3-phosphate dehydrogenase oxidizes G3P and attaches inorganic phosphate, producing 1,3-bisphosphoglycerate and reducing NAD+ to NADH.

  6. Substrate-level phosphorylation (ATP synthesis). Phosphoglycerate kinase transfers phosphate to ADP, producing 3-phosphoglycerate and ATP.

  7. Rearrangement and dehydration. Phosphoglycerate mutase and enolase convert 3-phosphoglycerate to 2-phosphoglycerate and then to phosphoenolpyruvate (PEP).

  8. Second substrate-level phosphorylation. Pyruvate kinase transfers phosphate from PEP to ADP, producing pyruvate and ATP.

  9. Fate of pyruvate. In aerobic conditions, pyruvate enters mitochondria for conversion to acetyl-CoA. Under anaerobic or high-flux conditions, it is reduced to lactate.

  10. Regulation. Hexokinase, PFK-1, and pyruvate kinase are the key regulatory enzymes. PFK-1 is allosterically activated by fructose-2,6-bisphosphate and AMP, inhibited by ATP and citrate. Insulin upregulates the pathway; glucagon and fasting suppress it.

Key Players / Molecular Components

  • Hexokinases. HK1, HK2, HK3, and glucokinase (HK4).
  • PFK-1 and PFK-2/FBPase-2. Bifunctional enzyme generating fructose-2,6-bisphosphate.
  • Aldolase, triose phosphate isomerase, GAPDH.
  • Phosphoglycerate kinase, phosphoglycerate mutase, enolase.
  • Pyruvate kinase. Isoforms M1 (muscle), M2 (proliferating cells, cancer), L (liver), R (red blood cells).
  • Lactate dehydrogenase. Regenerates NAD+ under anaerobic conditions.

Clinical Relevance / Therapeutic Targeting

Glycolytic dysregulation contributes to diabetes (impaired glucose clearance), cancer (the Warburg effect — enhanced glycolysis even under aerobic conditions, often via PKM2), and inherited glycolytic enzyme deficiencies (pyruvate kinase deficiency, phosphofructokinase deficiency). Drugs targeting glycolysis are under development in oncology (hexokinase inhibitors, PKM2 modulators, LDH inhibitors). Metformin indirectly influences glycolysis by activating AMPK. Exercise induces adaptations in glycolytic flux, and lactate itself is increasingly recognized as a signaling molecule.

Peptides That Target This Pathway

  • Insulin — upregulates GLUT4 trafficking and glycolytic enzyme expression.
  • GLP-1 analogs — improve glucose disposal indirectly through insulin secretion.
  • Glucagon — opposes glycolysis by promoting gluconeogenesis and glycogenolysis.
  • IGF-1 — activates glucose uptake and glycolytic flux through PI3K signaling.
  • MOTS-c — mitochondrial-derived peptide influencing glucose metabolism.

Related entries

  • GluconeogenesisGluconeogenesis is the metabolic pathway by which the liver and kidneys synthesize new glucose from non-carbohydrate precursors, maintaining blood sugar during fasting and prolonged exercise.
  • AMPK PathwayAMPK is a master cellular energy sensor that responds to metabolic stress by activating catabolic pathways, inhibiting anabolic processes, and restoring energy homeostasis — a central node connecting metabolism, longevity, and mitochondrial function.
  • GluconeogenesisThe hepatic and renal synthesis of glucose from non-carbohydrate precursors such as lactate, amino acids, and glycerol during fasting and exercise.
  • Insulin Receptor PathwayThe insulin receptor pathway translates circulating insulin into coordinated cellular responses that govern glucose uptake, lipid storage, protein synthesis, and growth.
  • Mitochondrial FunctionMitochondrial function encompasses the energy-producing, signaling, and quality-control processes within mitochondria, including oxidative phosphorylation, ROS management, apoptosis regulation, and the emerging biology of mitochondrial-derived peptides.